When an antidepressant has been tried at a reasonable dose for a reasonable length of time and the results still fall short, the conversation with your clinician usually turns to direction. Should you keep the medicine and add something alongside it, or should you stop it and try something else? Both paths are common in practice, and neither is a verdict on you. Understanding what each one involves can make the next visit feel less like a test you are failing and more like a planning discussion.
What adding a second treatment means
Augmenting means keeping your current medicine in place and bringing in another agent meant to work alongside it. Depending on the situation, clinicians may reach for a different antidepressant class, a mood stabilizer, or a lower dose of an antipsychotic, among other options. The reasoning is that two medicines may influence the illness through different pathways, so the combination may accomplish what neither did alone.
One practical appeal is continuity. Because the original medicine stays steady, you are not left without any support while the team experiments. That matters for people who have already felt the cost of a rough patch and want to avoid losing ground. Keeping something that has been partly helpful, whether that shows up as better sleep, a steadier appetite, or fewer hours of heavy dread, can make the change feel less risky.
The downside is that you would be juggling two medications, each with its own side effects and its own potential interactions to keep an eye on. Depending on what gets added, blood work, weight, and movement symptoms might need monitoring. Check with your clinician about which effects are specific to the new drug, and when they would expect you to be able to tell whether it is helping.
What switching to something new involves
Changing medications means discontinuing the current one, typically by tapering the dose down on a set schedule instead of quitting all at once, and then starting something else. Patients often make this move when the current drug produced side effects that outweighed its advantages, or when it appeared to do very little. A switch may remain within the same drug class or shift to a class that works through a different pathway.
If a medicine caused a troublesome reaction, such as heavy sedation, a rash, or a dangerous interaction with something else you take, a switch may be the sensible call no matter how the trial went overall. In that case, the question is less about whether the medicine worked and more about whether it can safely stay in your daily routine.
Switching carries its own work. Coming off a medicine can bring discontinuation symptoms, and the new medicine takes time to show its effect. During that stretch, you may feel worse before you feel better, or you may simply be in limbo for weeks while the new dose is adjusted. Planning the timing around work, travel, and family responsibilities matters. Many people find it helpful to write down the day they stop, the day they start, and the days they plan to check in, so the transition does not blur into guesswork.
How clinicians weigh the choice
The decision usually depends on what the last trial taught everyone. Was the problem a lack of effect, a side effect that could not be tolerated, or a mix of partial benefit and frustrating costs? Did the dose get high enough, and was it held long enough, to judge fairly? Your own history matters here too, including what has helped in the past and whether relatives responded well to particular medicines. A clear description of your sleep, energy, appetite, and daily function often tells the team more than a single mood rating does.
It is also worth asking your clinician what they would regard as evidence that the selected approach is working, and which developments would lead you to alter the plan. Settling on those indicators beforehand gives you both a common point of reference. Lacking that, it is easy to drift along for months, uncertain whether to continue or to move on.
Questions worth bringing to the visit
Before you agree to either path, consider bringing a short written list. You might ask what the main goal of the change is, which side effects are most likely, how long you should wait before judging the result, and what the backup plan is if the chosen move does not help. If cost or insurance approval will shape the timing, mention that early so it does not derail the plan later.
Neither adding nor switching is a loss of ground. Each is a way of learning more about how your depression responds to treatment, and each gives your care team information they did not have before. Keeping notes, speaking up about what you notice, and keeping the conversation open are the habits that make either path easier to follow through on.